Our comment to FDA about its use of the Pharmacy Compounding Advisory Committee (PCAC) was covered...
Related posts
UK-based pharmaphorum is covering the GLP-1 issue on this side of the pond — specifically Lilly’s...
One of the better articles we've seen lately comes from USA Today, explaining what is likely to...